1992
DOI: 10.1007/bf03008785
|View full text |Cite
|
Sign up to set email alerts
|

Prostaglandin E1 and carbon dioxide reactivity during cerebral aneurysm surgery

Abstract: The purpose of this study was to evaluate the effect of prostaglandin E I (PGEj) on CO 2 reactivity during cerebral aneurysm surgery in 37patients under neuroleptoanaesthesia (NLA ) (avant l'hypotension : 2,74 ._+ 0, pendant l'hypotension : 2,54 +__ O, apr~s l'hypotension : 2, que dans le groupe B ( avant I 'hypotension 1, 54 ._+ O, pendant l'hypotension 1, apr~s l'hypotension 1,49 ._+ 0, (P < O, 01

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

1997
1997
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…Several studies have assessed the time course of CVR in patients with ruptured intracranial aneurysms. CVR is often impaired in the early phase after aSAH [ 3 6 ], especially in patients with massive hemorrhage, poor neurological status at admission, and vasospasm [ 9 15 ]. There is a possible association between progressive impairment in CVR in the early phase after aSAH and subsequent development of delayed cerebral ischemia [ 9 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several studies have assessed the time course of CVR in patients with ruptured intracranial aneurysms. CVR is often impaired in the early phase after aSAH [ 3 6 ], especially in patients with massive hemorrhage, poor neurological status at admission, and vasospasm [ 9 15 ]. There is a possible association between progressive impairment in CVR in the early phase after aSAH and subsequent development of delayed cerebral ischemia [ 9 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…In healthy persons, CVR is stable over time [ 2 ]. In the early phase after aneurysmal subarachnoid hemorrhage (aSAH), CVR is often impaired [ 3 8 ], especially in patients with massive hemorrhage, poor neurological status at admission, and vasospasm [ 9 15 ]. It has been suggested that transient reduction of CVR after aSAH may be associated with development of delayed cerebral ischemia and poor outcome [ 9 , 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…The overall methodological quality was satisfying. Results after excluding articles inconsistent with our surgery timing definition showed no significant difference for poor outcome, with early vs intermediate treatment (RR 0.86[0.68,1.09]), early vs late (RR 0.99[0.70,1.40]). Subgroup analysis based on age showed that early surgery could obtain more favorable outcomes for death rate, with non-early group as reference when age ≥50 years (RR 0.52[0.29,0.93]).…”
Section: Resultsmentioning
confidence: 91%
“…952 articles were found to be ineligible based on irrelevant titles and abstracts. After detailed evaluation of the remaining 57 articles, 1 RCT (34) and 33 cohort studies (1,(4)(5)(6)(9)(10)(11)(12)14,16,17,(20)(21)(22)(23)(24)(25)(26)28,30,31,33,(36)(37)(38)40,41,43,44,46,47,49,52) were included for reasons described in Figure 1.…”
Section: █ Resultsmentioning
confidence: 99%
“…I NTRAVENOUS prostaglandin E 1 (PGE 1 ) is reported to be safe and useful for controlled hypotension during surgery (1). Its main advantages include a rapid onset of action, a quick recovery from hypotension (2) due to a short elimination half‐life, lack of toxicity, maintenance of adequate perfusion to vital organs (1, 3), and maintenance of cerebral blood flow reactivity to carbon dioxide (4, 5) during hypotension. The elimination half‐lives of PGE 1 are reported to be 0.2 min (alpha phase) and 8.2 min (β phase) (6).…”
mentioning
confidence: 99%